A multicenter analysis of clinical hemolysis in patients supported with durable, long-term left ventricular assist device therapy

Journal of Heart and Lung Transplantation

Volumn 34, Issue 5, 2015, Pages 701-709

  Katz, Jason N ^a   Jensen, Brian C ^a   Chang, Patricia P ^a   Myers, Susan L ^b   Pagani, Francis D ^c   Kirklin, James K ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Hemolysis; Outcomes; Survival; Thrombosis; Ventricular assist device

Indexed keywords

HEMOGLOBIN; INOTROPIC AGENT;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; ASSISTED CIRCULATION; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; FEMALE; FOLLOW UP; HEART RIGHT VENTRICLE FAILURE; HEART TRANSPLANTATION; HEMATOCRIT; HEMOLYSIS; HUMAN; INTRAAORTIC BALLOON PUMP; KIDNEY FAILURE; LEFT VENTRICULAR ASSIST DEVICE; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; PATIENT HISTORY OF CORONARY ARTERY BYPASS GRAFT; PRIORITY JOURNAL; RISK FACTOR; ADVERSE EFFECTS; BLOOD; CLINICAL TRIAL; EPIDEMIOLOGY; HEART ASSIST DEVICE; HEART FAILURE; KAPLAN MEIER METHOD; MIDDLE AGED; MULTICENTER STUDY; PHYSIOLOGY; REGISTER; RETROSPECTIVE STUDY; SURVIVAL RATE; TIME; TRENDS; UNITED STATES;

ADULT; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART-ASSIST DEVICES; HEMOLYSIS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; UNITED STATES;

EID: 84933180313     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2014.10.002     Document Type: Article

References (16)

1. Genovese EA, Dew MA, Teuteberg JJ, et al. Incidence and patterns of adverse event onset during the first 60 days after ventricular assist device implantation. Ann Thorac Surg 2009;88:1162-70.
2. Bennett M, Horton S, Thuys C, et al. Pump-induced haemolysis: a comparison of short-term ventricular assist devices. Perfusion 2004;19:107-11.
3. Heilmann C, Geisen U, Benk C, et al. Haemolysis in patients with ventricular assist devices: major differences between systems. Eur J Cardiothorac Surg 2009;36:580-4.
4. Slaughter MS, Sobieski MA, Gallagher C, et al. Fibrinolytic activation during long-term support with the HeartMate II left ventricular assist device. ASAIO J 2008;54:115-9.
5. Starling RC, Moazami N, Silvestry SC, et al. Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med 2013;370:33-40.
6. Kirklin JK, Naftel DC, Kormos RL, et al. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device. J Heart Lung Transplant 2014;33:12-22.
7. Uriel N, Han J, Morrison KA, et al. Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: a multifactorial phenomenon. J Heart Lung Transplant 2013;33:51-9.
8. Shah P, Mehta VM, Cowger JA, et al. Diagnosis of hemolysis and device thrombosis with lactate dehydrogenase during left ventricular assist device support. J Heart Lung Transplant 2013;33: 102-4.
9. Yasuda T, Shimokasa K, Funakubo A, et al. An investigation of blood flow behavior and hemolysis in artificial organs. ASAIO J 2000;46:527-31.
10. Alhosaini A, Jensen BC, Chang PP, et al. A novel link between G6PD deficiency and hemolysis in patients with continuous-flow left ventricular assist devices. J Heart Lung Transplant 2013;33:116-7.
11. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009;361:2241-51.
12. Pagani FD, Miller LW, Russell SD, et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol 2009;54:312-21.
13. Price EA, Schrier SL. Extrinsic nonimmune hemolytic anemias. In: Hoffman R, Furie B, Benz Jr, EJ, McGlave P, Silberstein LE, Shattil SJ, editors. Hematology: basic principles and practice. 6th ed. Philadelphia, PA: Saunders Elsevier; 2012: chap 45.
14. Kato GJ, Taylor JG. Pleiotropic effects of intravascular haemolysis on vascular homeostasis. Br J Haematol 2009;148:690-701.
15. Moazami N, Milano CA, John R, et al. Pump replacement for left ventricular assist device failure can be done safely and is associated with low mortality. Ann Thorac Surg 2013;95:500-5.
16. Stewart GC, Brooks K, Pratibhu PP, et al. Thresholds of physical activity and life expectancy for patients considering destination ventricular assist devices. J Heart Lung Transplant 2009;28:863-9.